Recent Comments

Comment RSS

Search results for 'Aldara'


Anadys Pharmaceuticals presents data showing ANA773 promotes anti-tumor activity of killer cells Anadys Pharmaceuticals presented data from an in vitro study showing that the active metabolite of ANA773 promotes natural killer (NK) cell-mediated anti-tumor response by inducing cytokine secretion, cytolysis of tumor cells and enhanced antibody-dependent cellular cytotoxicity (ADCC), during a poster presentation at the Annual Meeting of the American Association of Cancer Research (AACR) in Los Angeles. http://www.news-medical.net/news/2007/04/18/23740.aspx
New cream treatment for common form of skin cancer The US Food and Drug Administration has approved a new treatment for some people with a very common form of skin cancer. Imiquimod cream, sold as Aldara, can now be used to treat superficial basal cell carcinoma. http://www.news-medical.net/news/2004/07/23/3508.aspx
3M granted FDA approval for cream to treat superficial basal cell carcinoma 3M announced today that the U.S. Food and Drug Administration (FDA) has approved the first prescription therapy in nearly a decade for the treatment of superficial basal cell carcinoma (sBCC), a type of nonmelanoma skin cancer. http://www.news-medical.net/news/2004/07/16/3364.aspx
FDA approval for skin cancer cream 3M has received an "approvable" letter from the U.S. Food and Drug Administration (FDA) in response to its supplemental new drug application on Aldara (imiquimod) Cream, 5% for the treatment of superficial basal cell carcinoma (sBCC), a common form of non-melanoma skin cancer. http://www.news-medical.net/news/2004/04/14/526.aspx
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.